Technical Analysis for QDEL - Quidel Corporation

Grade Last Price % Change Price Change
grade B 64.19 0.33% 0.21
QDEL closed up 0.33 percent on Friday, September 20, 2019, on 1.52 times normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Down
See historical QDEL trend table...

Date Alert Name Type % Chg
20 DMA Support Bullish 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Cup with Handle Other 0.00%
MACD Bearish Signal Line Cross Bearish 0.33%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.33%
Cup with Handle Other 0.33%
Doji - Bullish? Reversal 0.33%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.58%
Cup with Handle Other 0.58%
Outside Day Range Expansion 0.58%

Older signals for QDEL ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Quidel Corporation develops, manufactures, and markets diagnostic testing solutions for applications in infectious diseases, women's health, and gastrointestinal diseases. The company's products for infectious diseases include QuickVue influenza test to detect viral antigens of influenza type A and B; QuickVue Strep A tests to detect Group A Streptococcal antigen from throat swabs or confirmation of presumptive Group A Streptococcal colonies recovered from culture; QuickVue RSV test, a rapid immunoassay for respiratory syncitial virus; and cell culture and DFA detection solutions to detect seven viral respiratory pathogens. It also offers cell-based products in various formats, including tubes, shell vials, and multi-well plates to culture and test for human viruses; ELVIS HSV system for the isolation and detection of herpes simplex virus (HSV) types 1 and 2; and a multiplex cell culture solution to isolate HSV, varicella zoster virus, and cytomegalovirus, as well as provides various analyzers and molecular assays. The company's products for women's health consist of QuickVue and RapidVue pregnancy tests to detect human chorionic gonoadotropin in serum or urine for the early detection of pregnancy; Thyretain for the diagnosis of graves, an autoimmune disease; QuickVue Chlamydia test to detect chlamydia trachomatis from endocervical swab and cytology brush specimens; and clinical and research products for the assessment of osteoporosis and the evaluation of bone resorption/formation, including metabolic bone markers to monitor the effectiveness of therapy in pharmaceutical and related research. In addition, it provides a fecal immunochemical test to detect the presence of blood in stool specimens; indirect fluorescent antibody products; and Helicobacter pylori tests, as well as develops diagnostic and research products in the fields of oncology, bone health, and autoimmune diseases. The company was founded in 1979 and is headquartered in San Diego, California.
Medicine Medical Specialties Infectious Diseases Autoimmune Diseases Influenza Infectious Causes Of Cancer Autoimmune Disease Gastrointestinal Diseases Osteoporosis Herpes Simplex Virus Sexually Transmitted Diseases And Infections Detection Solutions
Is QDEL a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 70.31
52 Week Low 44.27
Average Volume 223,972
200-Day Moving Average 59.2392
50-Day Moving Average 60.3102
20-Day Moving Average 63.078
10-Day Moving Average 65.672
Average True Range 2.497
ADX 17.44
+DI 27.4075
-DI 22.6561
Chandelier Exit (Long, 3 ATRs ) 62.509
Chandelier Exit (Short, 3 ATRs ) 64.201
Upper Bollinger Band 69.8095
Lower Bollinger Band 56.3465
Percent B (%b) 0.58
BandWidth 21.343416
MACD Line 1.3875
MACD Signal Line 1.5569
MACD Histogram -0.1693
Fundamentals Value
Market Cap 2.14 Billion
Num Shares 33.3 Million
EPS 0.00
Price-to-Earnings (P/E) Ratio 0.00
Price-to-Sales 6.50
Price-to-Book 6.54
PEG Ratio 7.17
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 67.04
Resistance 3 (R3) 66.93 65.86 66.57
Resistance 2 (R2) 65.86 65.14 65.92 66.41
Resistance 1 (R1) 65.03 64.69 65.45 65.14 66.25
Pivot Point 63.96 63.96 64.17 64.02 63.96
Support 1 (S1) 63.13 63.24 63.55 63.24 62.13
Support 2 (S2) 62.06 62.79 62.12 61.97
Support 3 (S3) 61.23 62.06 61.82
Support 4 (S4) 61.34